Cas no 438530-82-6 (3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde)
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde Chemical and Physical Properties
Names and Identifiers
-
- 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde
- 3-(2,6-dimethylphenoxymethyl)-4-methoxybenzaldehyde
- 3-(2,6-Dimethyl-phenoxymethyl)-4-methoxy-benzaldehyde
- AC1LBXU9
- AG-690
- CTK7A6312
- Oprea1_340182
- Oprea1_477247
- STK346894
- 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde #
- EN300-227633
- 3-((2,6-Dimethylphenoxy)methyl)-4-methoxybenzaldehyde
- Benzaldehyde, 4-methoxy-3-(2,6-dimethylphenoxymethyl)-
- DTXSID40343605
- E84380
- ALBB-001079
- 438530-82-6
- MFCD02055669
- VS-04027
- AG-690/15433677
- BBL013860
- Z275169928
- SCHEMBL2548051
- CS-0215157
- 4-methoxy-3-(2,6-dimethylphenoxymethyl)-benzaldehyde
- AKOS000304054
-
- MDL: MFCD02055669
- Inchi: 1S/C17H18O3/c1-12-5-4-6-13(2)17(12)20-11-15-9-14(10-18)7-8-16(15)19-3/h4-10H,11H2,1-3H3
- InChI Key: CPXYVPDEEYJVDE-UHFFFAOYSA-N
- SMILES: O(CC1C=C(C=O)C=CC=1OC)C1C(C)=CC=CC=1C
Computed Properties
- Exact Mass: 270.12600
- Monoisotopic Mass: 270.125594432g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 20
- Rotatable Bond Count: 5
- Complexity: 295
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.5
- Topological Polar Surface Area: 35.5?2
Experimental Properties
- PSA: 35.53000
- LogP: 3.70350
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde Customs Data
- HS CODE:2912499000
- Customs Data:
China Customs Code:
2912499000Overview:
2912499000. Other aldehyde ethers\Aldehydes, phenols and aldehydes containing other oxygen-containing groups. VAT:17.0%. Tax refund rate:9.0%. Regulatory conditions:nothing. MFN tariff:5.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to, Appearance of tetraformaldehyde
Summary:
2912499000. other aldehyde-ethers, aldehyde-phenols and aldehydes with other oxygen function. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:5.5%. General tariff:30.0%
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 014213-1g |
3-(2,6-Dimethylphenoxymethyl)-4-methoxy-benzaldehyde |
438530-82-6 | 1g |
£205.00 | 2022-03-01 | ||
| Fluorochem | 014213-5g |
3-(2,6-Dimethylphenoxymethyl)-4-methoxy-benzaldehyde |
438530-82-6 | 5g |
£715.00 | 2022-03-01 | ||
| Fluorochem | 014213-10g |
3-(2,6-Dimethylphenoxymethyl)-4-methoxy-benzaldehyde |
438530-82-6 | 10g |
£1225.00 | 2022-03-01 | ||
| TRC | D592273-100mg |
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde |
438530-82-6 | 100mg |
$ 70.00 | 2022-06-05 | ||
| TRC | D592273-500mg |
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde |
438530-82-6 | 500mg |
$ 230.00 | 2022-06-05 | ||
| TRC | D592273-1g |
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde |
438530-82-6 | 1g |
$ 340.00 | 2022-06-05 | ||
| abcr | AB378144-500 mg |
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde |
438530-82-6 | 500MG |
€195.40 | 2022-06-10 | ||
| abcr | AB378144-1 g |
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde |
438530-82-6 | 1g |
€239.00 | 2023-04-25 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1285827-100mg |
3-[(2,6-dimethylphenoxy)methyl]-4-methoxybenzaldehyde |
438530-82-6 | 98% | 100mg |
¥657.00 | 2024-05-13 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1285827-250mg |
3-[(2,6-dimethylphenoxy)methyl]-4-methoxybenzaldehyde |
438530-82-6 | 98% | 250mg |
¥1059.00 | 2024-05-13 |
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde Related Literature
-
Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
-
Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
-
Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
Additional information on 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde
Research Brief on 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde (CAS: 438530-82-6)
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde (CAS: 438530-82-6) is a synthetic organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and medicinal chemistry. This research brief aims to provide an overview of the latest findings related to this compound, including its synthesis, biological activity, and potential therapeutic uses.
Recent studies have focused on the synthesis and optimization of 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde, with particular emphasis on improving yield and purity. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and ensure its structural integrity. These efforts are critical for its potential use as a building block in the development of novel pharmaceuticals.
In terms of biological activity, preliminary research suggests that 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde exhibits promising pharmacological properties. In vitro studies have demonstrated its ability to modulate specific enzymatic pathways, which could be leveraged for the treatment of various diseases, including inflammatory disorders and certain types of cancer. However, further in vivo studies are required to validate these findings and assess the compound's safety and efficacy.
The compound's mechanism of action appears to involve interaction with key cellular targets, although the exact pathways remain under investigation. Researchers are particularly interested in its potential as an inhibitor or activator of specific proteins, which could open new avenues for targeted therapy. Collaborative efforts between academic institutions and pharmaceutical companies are underway to explore these possibilities.
Despite its potential, challenges remain in the development of 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde as a therapeutic agent. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through rigorous preclinical testing. Additionally, the scalability of its synthesis must be optimized to meet the demands of large-scale pharmaceutical production.
In conclusion, 3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde represents a promising candidate for further research in the field of medicinal chemistry. Its unique structural features and biological activity make it a valuable subject of study, with potential applications in drug discovery and development. Continued investigation into its properties and mechanisms will be essential to fully realize its therapeutic potential.
438530-82-6 (3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde) Related Products
- 14389-86-7(2-Benzyloxybenzoic acid)
- 438219-52-4(4-Methoxy-3-[(4-methylphenoxy)methyl]benzaldehyde)
- 820234-27-3(Benzoic acid, 2-[(2-methoxyphenyl)methoxy]-)
- 329222-82-4(4-Methoxy-3-[(2-methylphenoxy)methyl]benzaldehyde)
- 144896-51-5(4-(Benzyloxy)-3,5-dimethylbenzaldehyde)
- 848607-07-8(Benzoic acid, 5-formyl-2-[(4-methoxyphenyl)methoxy]-)
- 76646-41-8(4-Methoxy-3-(methoxymethyl)benzaldehyde)
- 744242-83-9(2-(3-Methylphenyl)methoxybenzoic Acid)
- 917746-81-7(4-Ethoxy-3-(hydroxymethyl)benzaldehyde)
- 158771-31-4(Benzaldehyde, 3-methyl-4-(phenylmethoxy)- (Related Reference))